News & Announcements

May 2023 | Statement

Regina Tamés and Jay Zussman join Ibis Board of Directors; Fatimah Gifford starts term as Board Chair

We are thrilled to announce that Regina Tamés and Jay Zussman have joined the Ibis Board of Directors as Members at Large, and Fatimah Gifford is starting her term as Board Chair. Fatimah will be building on the work of former Board Chair Thoai Ngo to continue to advance racial justice and...

April 2023 | Statement

Ibis responds to federal court decisions on mifepristone registration and availability

Cambridge, MA, April 10, 2023 – On Friday, April 7, 2023, a judge in a Texas federal court released a ruling in Alliance for Hippocratic Medicine v. FDA. The ruling places a stay on the FDA’s approval of mifepristone and seeks to remove it from the market nationwide. The same day...

March 2023 | Media

A new battle in the war on abortion pills

March 2023 | Statement

AMAZE Africa media event amplified sexuality education in Sub-Saharan Africa

Insights from the World Population Review indicate that over 13 million children are born to women who are under 20 years old. Disturbingly, more than 90% of these births (about 12 million) occur in developing countries, with African countries topping the list. To address high rates of teenage...

March 2023 | Statement

Exciting new partnership will advance comprehensive sexuality education in sub-Saharan Africa

Ibis Reproductive Health South Africa is proud to announce its partnership with Advocates For Youth (AFY) as the new Sub-Saharan Africa regional lead for the AMAZE Africa initiative, with the intention of amplifying ongoing efforts in the region to make comprehensive sexuality education resources...

March 2023 | Statement

FDA schedules advisory committee meeting for over-the-counter birth control pill to take place May 9-10

The FDA announced today that an advisory committee meeting is scheduled for May 9 and 10 to review the first-ever application for an over-the-counter birth control pill. In July 2022, HRA Pharma announced it had submitted this application to the FDA to switch Opill, a progestin-only, daily birth...

October 2022 | Statement

Ibis responds to FDA’s announcement to postpone advisory committee meeting for over-the-counter birth control pill

We are frustrated and deeply disappointed by the FDA’s delay of the advisory committee meeting to discuss the application to move a progestin-only birth control pill over the counter (OTC). Birth control pills are safe and effective, and over-the-counter availability would expand equitable...

August 2022 | Statement

New partnership will expand access to comprehensive sexuality education resources in Africa

(Johannesburg, South Africa) – Ibis Reproductive Health, South Africa office is excited to announce a partnership with AMAZE.org , a project of Advocates for Youth implemented in collaboration with organizations around the world. AMAZE.org harnesses the power of digital media to provide...

July 2022 | Media

Let’s talk about Misoprostol—the original abortion pill

July 2022 | Statement

New survey reveals difficulties accessing abortion in Indiana, foreshadows worsening harms now that Roe v. Wade is overturned

With Indiana already ranked #2 in United States for number of restrictive abortion laws, researchers say additional barriers could harm Hoosiers even further (Indianapolis, IN) – Following the US Supreme Court’s decision to overturn Roe v. Wade , a new survey shows that one thing...

July 2022 | Statement

Ibis celebrates the first-ever application for an OTC birth control pill in the United States

For nearly two decades, Ibis Reproductive Health has led a coalition-driven effort involving more than 100 reproductive health, rights, and justice organizations, research and advocacy groups, youth activists, health care providers, prominent medical and health professional associations, regulatory...

June 2022 | Statement

Ibis responds to overturn of Roe v. Wade

Cambridge, MA, June 24, 2022 – Today, the US Supreme Court released a final decision on Dobbs v. Jackson Women’s Health Organization . The decision overturns Roe v. Wade , the ruling that established the constitutional right to abortion in 1973. The case was focused on whether...

News & Announcements

Pages